Beta Bionics, Inc. Common Stock (BBNX) support and resistance · rev $100.3M
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
This page maps Beta Bionics, Inc. Common Stock (BBNX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
BBNX currently screens at market cap $640.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BBNX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BBNX quote page for the session range and the stock page for the full model.
Not investment advice.